Publicacións en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (50)

2024

  1. Combining imaging mass spectrometry and immunohistochemistry to analyse the lipidome of spinal cord inflammation

    Analytical and Bioanalytical Chemistry, Vol. 416, Núm. 8, pp. 1923-1933

2023

  1. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

    Autophagy, Vol. 19, Núm. 7, pp. 1952-1981

  2. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2021

  1. Effects of platelet-rich plasma on cellular populations of the central nervous system: The influence of donor age

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-20

2020

  1. An overground robotic gait training program for people with multiple sclerosis: A protocol for a randomized clinical trial

    Frontiers in Medicine, Vol. 7

  2. Functional and Metabolic Characterization of Microglia Culture in a Defined Medium

    Frontiers in Cellular Neuroscience, Vol. 14

  3. In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke

    Theranostics, Vol. 11, Núm. 1, pp. 410-425

  4. N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function

    Annals of Neurology, Vol. 87, Núm. 5, pp. 670-676

2019

  1. Excitotoxicity therapy for stroke patients still alive

    EBioMedicine

  2. Purinergic receptors in multiple sclerosis pathogenesis

    Brain Research Bulletin, Vol. 151, pp. 38-45

  3. Targeting P2X4 and P2X7 receptors in multiple sclerosis

    Current Opinion in Pharmacology, Vol. 47, pp. 119-125

2018

  1. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia

    GLIA, Vol. 66, Núm. 8, pp. 1611-1624

  2. Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling

    Therapeutic Advances in Neurological Disorders, Vol. 11

  3. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

    EMBO Molecular Medicine, Vol. 10, Núm. 8

2016

  1. Cystine/glutamate antiporter blockage induces myelin degeneration

    GLIA, Vol. 64, Núm. 8, pp. 1381-1395

  2. Erratum: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling (PLoS Biology (2016) 14:5 (e1002466) DOI: 10.1371/journal.pbio.1002466)

    PLoS Biology

  3. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Núm. 6, pp. 1124-1138

  4. Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling

    PLoS Biology, Vol. 14, Núm. 5

  5. PET imaging with [18F]FSPG evidences the role of system xc- on brain inflammation following cerebral ischemia in rats

    Theranostics, Vol. 6, Núm. 11, pp. 1753-1767

2015

  1. In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia

    Journal of Neuroscience, Vol. 35, Núm. 15, pp. 5998-6009